Detailed tests and scans eventually revealed the cause - an advanced stage of clear cell ovarian cancer. For another patient, Michelle (not her real name), aged 49, the road to diagnosis came in late ...

Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time RNA-seq data from 522 patients with ccRCC ...

The Phase 2 LARA trial reported encouraging activity for pembrolizumab plus lenvatinib in recurrent gynaecological clear cell ...

The AI model demonstrated an AUC of 0.71, which was significantly higher than the AUC of 0.54 reached using the tumor size-based model An artificial intelligence (AI)-based model for analyzing images ...

Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a ...